期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients 被引量:15
1
作者 Ahmed A.Alnagdy Hossam Y.Abouelkheir +1 位作者 Sherief E.El-Khouly Sahar M.Tarshouby 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第4期616-622,共7页
AIM: To evaluate the efficacy of prophylactic administration of topical non-steroidal anti-inflammatory drugs(NSAIDs) on macular edema following cataract surgery in diabetic patients, and to compare between types o... AIM: To evaluate the efficacy of prophylactic administration of topical non-steroidal anti-inflammatory drugs(NSAIDs) on macular edema following cataract surgery in diabetic patients, and to compare between types of NSAIDs(ketorolac tromethamine 0.4% and nepafenac 0.1%). METHODS: Group 1(control) received artificial tears substitute as a placebo group, group 2(nepafenac) received topical nepafenac 0.1%, and group 3(ketorolac) received topical ketorolac tromethamine 0.4%. Patients were examined postoperatively after completing one week, one month, two months and three months' intervals for evaluating cystoid macular edema(CME) development. The main study outcomes were achieving the best corrected visual acuity(BCVA) and change in the central macular thickness(CMT) measured with optical coherence topography(OCT).RESULTS: Eighty eyes of 76 patients were included in this study. BCVA showed a statistically significant difference at the third month postoperative follow up between the control group and the NSAIDs groups(P=0.04). There was an increase in the CMT in all cases starting from postoperative first week until third month. CMT showed a statistically significant difference between control group and NSAIDs groups from postoperative first month until third month(P=0.008, 0.027, 0.004). There was no statistically significant difference between nepafenac and ketorolac groups in BCVA and OCT CMT. CONCLUSION: Prophylactic preoperative and postoperative NSAIDs may have a role in reducing the frequency and severity of CME in diabetic eyes following cataract surgery. 展开更多
关键词 diabetes mellitus cataract surgery central macular thickness non-steroidal anti-inflammatory drugs ketorolac nepafenac
下载PDF
Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes:A meta-analysis of randomised controlled trials
2
《South China Journal of Cardiology》 CAS 2013年第3期211-212,共2页
Background The choice between coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) for revascularisation in patients with diabetes and multivessel coronary artery disease, who accoun... Background The choice between coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) for revascularisation in patients with diabetes and multivessel coronary artery disease, who account for 25% of revascularisation procedures, is much debated. We aimed to assess whether all-cause mortality differed be- tween patients with diabetes who had CABG or PCI by doing a systematic review and meta-analysis of ran- domised controlled trials (RCTs) comparing CABG with PCI in the modem stent era. 展开更多
关键词 CABG Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes PCI
原文传递
Basal insulin therapy strategy is superior to premixed insulin therapy in the perioperative period blood glucose management 被引量:4
3
作者 Huang Qing-xian Lou Fu-chen +9 位作者 Wang Ping Liu Qian Wang Kun Zhang Li Zhu Lei Yu Shan Xu Hua Wang Qian Zhang Ying Hou Wei-kai 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第21期4030-4036,共7页
Background The probability and risk of operations increase in patients with type 2 diabetes mellitus. For diabetic patients, blood glucose control is a key factor to improving the prognosis of surgery. During perioper... Background The probability and risk of operations increase in patients with type 2 diabetes mellitus. For diabetic patients, blood glucose control is a key factor to improving the prognosis of surgery. During perioperative period, insulin therapy is usually advised to be used for surgical patients with type 2 diabetes. However, the insulin regimen which one is better remains controversial. In this study, we estimated the efficacy, safety and advantage of different insulin therapy strategy during perioperative period. 展开更多
关键词 diabetes surgery insulin therapy perioperative period
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部